dpp 4 inhibitors vs glp 1 Novel Potentials of the DPP-4 Inhibitor Sitagliptin against Ischemia-Reperfusion (I/R) Injury in Rat Ex-Vivo Heart Model The pharmacology of DPP-4 inhibitors

10.1152/ajprenal.00036.2017 22 DoiS.MasakiT.ArakawaT.TakahashiS.KawaiT.NakashimaA.et al (2007)

Neuron 2017;96:897-909.ArticlePubMedPMC 95

Serum uric acid and prognosis of ischemic stroke: Cohort study, meta-analysis and Mendelian randomization study

Trusted Resources to Learn More To stay current on weight control pharmacology, nurses can explore the following resources: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) American Gastroenterological Association Obesity Guidelines FDA Drug Safety and Medication Guides These sources provide reliable, evidence-based updates on weight management therapies, including GLP-1 receptor agonists

Recalls & Warnings December 05, 2018 Seller of Cold and Flu Supplements, "SuperFood" & More Warned by FDA On October 30, 2018, the FDA issued a warning letter to American Botanical Pharmacy following a review of the company's website (www.herbdoc.com) and Facebook page, which found statements made about some of its products to be drug claims

Total eNOS and activated eNOS were significantly lower in HUVECs treated with ET-1-generated EMVs compared with control EMVs